1. Home
  2. MREO vs OM Comparison

MREO vs OM Comparison

Compare MREO & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

SELL

Current Price

$0.30

Market Cap

50.3M

Sector

Health Care

ML Signal

SELL

Logo Outset Medical Inc.

OM

Outset Medical Inc.

SELL

Current Price

$3.41

Market Cap

59.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MREO
OM
Founded
2015
2003
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.3M
59.2M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
MREO
OM
Price
$0.30
$3.41
Analyst Decision
Buy
Buy
Analyst Count
8
3
Target Price
$1.96
★ $7.67
AVG Volume (30 Days)
★ 632.5K
93.2K
Earning Date
11-09-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 16.67
N/A
EPS
★ N/A
N/A
Revenue
$500,000.00
★ $119,476,000.00
Revenue This Year
$59.51
$6.72
Revenue Next Year
$2,326.81
$9.25
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 5.09
52 Week Low
$0.20
$2.84
52 Week High
$2.37
$6.49

Technical Indicators

Market Signals
Indicator
MREO
OM
Relative Strength Index (RSI) 50.90 36.72
Support Level $0.27 $3.00
Resistance Level $0.35 $3.69
Average True Range (ATR) 0.02 0.32
MACD 0.00 -0.09
Stochastic Oscillator 62.55 6.70

Price Performance

Historical Comparison
MREO
OM

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About OM Outset Medical Inc.

Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.

Share on Social Networks: